Insulin Aspart
Overview
Insulin Aspart is a rapid-acting human insulin analog used to improve glycemic control in adults and children with diabetes mellitus. It is structurally similar to human insulin, with a rapid onset and short duration of action.
API suppliers (5)
Suppliers of Insulin Aspart evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
- Amphastar Nanjing PharmaceuticalsChina1 active DMF
- NINGBO KUNPENG BIOTECH CO LTDChina1 active DMF
- HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina1 active DMF
- YIFAN PHARMACEUTICAL (SHANGHAI) CO LTD1 active DMF
- NANJING CELLNUO BIOPHARMACEUTICAL CO LTDChina1 active DMF
Therapeutic areas
Do you supply Insulin Aspart? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.